Effect of ACE inhibitor on early kidney hypertrophy and its mechanism in diabetic rats

吴永贵,林善锬

DOI: https://doi.org/10.3321/j.issn:1001-1978.2003.03.015

2003-01-01

Abstract:AIM: To explore the effect of ACE inhibitor on early kidney hypertrophy and its mechanism in diabetic rats. METHODS: Rats were randomly divided into three groups: uninephrectomized rats, streptozotocin induced diabetic rats and diabetic rats treated with benazepril (an ACE inhibitor, 10 mg · kg-1 · d-1, ig). Activity of ACE was determined by the fluorimetric assay. Expression of TGFβ1, mRNA and TGFβ1 and p21CIP1 protein was measured by Northern blot analysis and Western blot analysis, respectively. RESULTS: After 1 week, the diabetic rats developed a body weight loss, kidney weight/body weight increased and renal cortex ACE activity elevated despite a decrease in plasma ACE activity. Northern blot analysis showed that renal cortex TGFβ1 mRNA expression in the diabetic rats was enhanced by 1.3 times, compared with uninephrectomized rats. Western blot analysis showed that TGFβ1 and p21CIP1 protein expression were also increased. Administration of benazepril for one week significantly suppressed kidney hypertrophy. ACE activity in the plasma, renal cortex and medulla was reduced by 89%, 70%, and 70.5%, respectively. Expression of TGFβ1 mRNA as well as expression of TGFβ1 and p21CIP1 protein was reduced by 47.7%, 49.5%, and 60.0%, respectively. CONCLUSION: Our results suggest that the suppression of ACE inhibitor on diabetic kidney hypertrophy might partially be associated with a decrease in the expression of TGFβ1 and p21CIP1 in diabetic rats renal cortex. However, its exact mechanism remains to be further explored.